Abstract Details

Title White Matter Integrity is Associated with Early Neurologic Improvement After Ischemic Stroke

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) S40 - (-)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Mark R. Etherton, MD (Massachusetts General Hospital) PRESENTER	Dr. Etherton has received personal compensation for serving as an employee of Takeda Pharmaceutical Company. Dr. Etherton has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Argenica Therapeutics.
	No disclosure on file
Anne-Katrin Giese, MD (University Medical Center Hamburg-Eppendorf)	Dr. Giese has nothing to disclose.
Arne Lauer, MD (Goethe University)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Kathleen L. Donahue (Massachusetts General Hospital)	No disclosure on file
William A. Copen	No disclosure on file
	No disclosure on file
Natalia S. Rost, MD, MPH, FAAN, FAHA (Massachusetts General Hospital)	Dr. Rost has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for ��ɫ��. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.

��ɫ����